The assessment of experimental artificial intelligence (AI) algorithms for the diagnosis of skin tumours against human performance
- Conditions
- Skin tumour diagnosisskin cancermelanomaSkin - Dermatological conditionsCancer - Malignant melanomaCancer - Non melanoma skin cancer
- Registration Number
- ACTRN12620000695909
- Lead Sponsor
- MetaOptima Technology Inc
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 190
A. Whole body examination
1. Patients with baseline total body photographs (TBP) taken within 1-4 years of examination
2. Gender: Male or Female
3. Age range: 18-99yrs
4. Modified Fitzpatrick I-III Skin Type
5. Willingness and ability to provide informed consent and to participate and comply with the study requirements.
B. Individual lesion examination
1. Patients undergoing an excision/biopsy of a pigmented skin lesion.
2. Gender: Male or Female
3. Age range: 18-99yrs
4. Modified Fitzpatrick I-III Skin Type
5. Willingness and ability to provide informed consent and to participate and comply with the study requirements.
Not meeting all inclusion criteria for either group A or B.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method